Study type

Study topic

DiseaseĀ /health condition
Human medicinal product

Study type

Non-interventional study

Scope of the study

Assessment of risk minimisation measure implementation or effectiveness

Data collection methods

Secondary use of data
Non-interventional study

Non-interventional study design

Cohort
Study drug and medical condition

Name of medicine

PLAVIX

Name of medicine, other

Effient

Medical condition to be studied

Acute coronary syndrome
Population studied

Short description of the study population

Patients 18 years of age or older who were diagnosed with acute myocardial infarction (MI) and managed in any of 213 cardiology units of French hospitals.
Patients who were included in this report were required to be in the FAST-MI registry for 12 months after index hospitalisation.

Age groups

Children (2 to < 12 years)
Adolescents (12 to < 18 years)
Adults (18 to < 46 years)
Adults (46 to < 65 years)
Adults (65 to < 75 years)
Adults (75 to < 85 years)
Adults (85 years and over)

Special population of interest

Other

Special population of interest, other

Acute myocardial infarction patients

Estimated number of subjects

2644
Study design details

Main study objective

To describe prasugrel and clopidogrel routine use, and clinical outcomes. For more details, refer to the study report attached.

Outcomes

Bleeding

Data analysis plan

Continuous variables are presented with the sample size, mean, standard deviation, median, 1st and 3rd quartiles, and number of missing responses. Categorical variables are presented with count, percentage, and number of missing. All the analyses were descriptive without adjustments.For descriptive analyses, missing responses were counted and excluded from the analysis for each variable separately. No data imputation techniques were planned.For more details, refer to study report